Bionano Genomics (BNGO) Expected to Announce Earnings on Wednesday

Bionano Genomics (NASDAQ:BNGO) is anticipated to post its quarterly earnings results before the market opens on Wednesday, March 12th. Analysts expect Bionano Genomics to post earnings of ($8.40) per share and revenue of $6.20 million for the quarter.

Bionano Genomics Stock Performance

NASDAQ BNGO opened at $3.71 on Tuesday. The firm has a 50-day moving average of $8.46 and a 200-day moving average of $16.00. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.99 and a current ratio of 1.43. The stock has a market cap of $10.14 million, a PE ratio of -0.03 and a beta of 2.24. Bionano Genomics has a 52-week low of $3.66 and a 52-week high of $72.60.

Analyst Ratings Changes

Separately, LADENBURG THALM/SH SH cut shares of Bionano Genomics from a “buy” rating to a “neutral” rating in a research note on Friday, November 15th.

Bionano Genomics Company Profile

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.